- Home
- / BCN Peptides
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BCN Peptides financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
€30.9 M
Y, 2021
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | Y, 2019 | Y, 2020 | Y, 2021 |
|---|---|---|---|
| Revenue | 32.6M | 32.1M | 30.9M |
| Cost of goods sold | 6.2M | 6.6M | 5.4M |
| Gross profit | 26.4M | 25.5M | 25.6M |
| Gross profit margin, % | 81.0% | 79.4% | 82.7% |
| General and administrative expense | 4.7M | 4.6M | 4.8M |
| Operating expense total | 8.2M | 8.4M | 9.7M |
| Depreciation and amortization | 813.9K | 854.3K | 790.1K |
| EBIT | 20.1M | 20.9M | 18.1M |
| EBIT margin, % | 61.8% | 65.3% | 58.5% |
| Interest income | 674.5K | 302.5K | 104.2K |
| Interest expense | 3.4K | 11.1K | 2.6K |
| Pre tax profit | 20.5M | 20.4M | 19.6M |
| Income tax expense | 5.5M | 4.4M | 4.0M |
| Net Income | 15.0M | 16.0M | 15.6M |